| scholarly article | Q13442814 |
| P2093 | author name string | C. Tang | |
| P. Vadas | |||
| W. Pruzanski | |||
| B. P. Kennedy | |||
| M. Kwan | |||
| D. E. Rancourt | |||
| W. A. Cromlish | |||
| J. Mudgett | |||
| P. Payette | |||
| P2860 | cites work | mouse genome | Q16765998 |
| Protective effects of a leukotriene inhibitor and a leukotriene antagonist on endotoxin-induced mortality in carrageenan-pretreated mice. | Q33366153 | ||
| Identification of a novel exonic mutation at -13 from 5' splice site causing exon skipping in a girl with mitochondrial acetoacetyl-coenzyme A thiolase deficiency | Q34131561 | ||
| Bactericidal properties of murine intestinal phospholipase A2. | Q34200767 | ||
| Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines | Q34267275 | ||
| The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia | Q34313013 | ||
| Enhancing factor protein from mouse small intestines belongs to the phospholipase A2 family | Q34359700 | ||
| Structure of gene coding for rat group II phospholipase A2. | Q34610083 | ||
| Expression of enhancing factor gene and its localization in mouse tissues | Q34687826 | ||
| Structure of genomic DNA for rat platelet phospholipase A2. | Q34979098 | ||
| Suppression of inflammatory responses to 12-O-tetradecanoyl-phorbol-13-acetate and carrageenin by YM-26734, a selective inhibitor of extracellular group II phospholipase A2 | Q36330372 | ||
| The mutation and polymorphism of the human beta-globin gene and its surrounding DNA. | Q40075998 | ||
| Mammalian non-pancreatic phospholipases A2. | Q40770475 | ||
| Phospholipase A2 and arthritis | Q40874634 | ||
| Detection of 14-kDa group II phospholipase A2 in human seminal plasma | Q43581004 | ||
| Novel inhibitor of phospholipase A2 with topical anti-inflammatory activity | Q43602121 | ||
| Characterization of a spontaneously occurring arthritis in male DBA/1 mice | Q43846987 | ||
| Further studies on the enhancing factor and its possible mechanism of action | Q46306981 | ||
| N-(carboxymethyl)-N-[3,5-bis(decyloxy)-phenyl]glycine (Ro 23-9358): a potent inhibitor of secretory phospholipases A2 with antiinflammatory activity | Q47565088 | ||
| Enhancing factor, a Paneth cell specific protein from mouse small intestines: predicted amino acid sequence from RT-PCR amplified cDNA and its expression | Q48100748 | ||
| Cloning of the cDNA coding for 14 kDa group II phospholipase A2 from rat liver | Q48110186 | ||
| Ontogeny of enhancing factor in mouse intestines and skin | Q52239138 | ||
| Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. | Q54598631 | ||
| Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock | Q54684806 | ||
| Enhanced expression of group II phospholipase A2 gene in the tissues of endotoxin shock rats and its suppression by glucocorticoid. | Q54707109 | ||
| Proteoglycan-induced arthritis in balb/c mice | Q61658728 | ||
| Purification of a soluble phospholipase A2 from synovial fluid in rheumatoid arthritis | Q68985581 | ||
| Antiinflammatory action of thielocin A1 beta, a group II phospholipase A2 specific inhibitor, in rat carrageenan-induced pleurisy | Q70710580 | ||
| Discovery of new non-phospholipid inhibitors of the secretory phospholipases A2 | Q72289341 | ||
| Synovial-type (group II) phospholipase A2 human seminal plasma | Q72702623 | ||
| Association of hyperphospholipasemia A2 with multiple system organ dysfunction due to salicylate intoxication | Q72801135 | ||
| P433 | issue | 38 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 22378-22385 | |
| P577 | publication date | 1995-09-01 | |
| 1995-09-22 | |||
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains | |
| A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains | |||
| P478 | volume | 270 |
| Q91303789 | A Potential Role of Phospholipase 2 Group IIA (PLA2-IIA) in P. gingivalis-Induced Oral Dysbiosis |
| Q41522207 | A Reassessment of the Low Molecular Weight Phospholipase A2 Gene Family in Mammals |
| Q34509270 | A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism |
| Q35187404 | A genome-wide association study in large white and landrace pig populations for number piglets born alive |
| Q35776615 | A new era of secreted phospholipase A₂ |
| Q34681820 | A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis |
| Q28306525 | A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs |
| Q28513976 | A novel group of phospholipase A2s preferentially expressed in type 2 helper T cells |
| Q34503409 | ATP binding cassette G1-dependent cholesterol efflux during inflammation |
| Q35550092 | Accelerated fracture healing in mice lacking the 5-lipoxygenase gene |
| Q52668552 | Activation of Notch-1 in oral epithelial cells by P. gingivalis triggers the expression of the antimicrobial protein PLA2-IIA. |
| Q73084769 | Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1 |
| Q42454789 | Agonist-specific alterations in receptor-phospholipase coupling following inactivation of Gi2alpha gene |
| Q79291782 | Amyloidosis Modifier Genes in the Less Amyloidogenic A/J Mouse Strain |
| Q53364291 | Analysis of reciprocal congenic lines reveals the C3H/HeJ genome to be highly resistant to ApcMin intestinal tumorigenesis. |
| Q27026893 | Antimicrobial compounds in tears |
| Q42831782 | Arachidonic acid inhibits osteoblast differentiation through cytosolic phospholipase A2-dependent pathway |
| Q30499792 | Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models |
| Q33595339 | Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. |
| Q34667102 | Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice |
| Q44272178 | Brain lipid metabolism in the cPLA2 knockout mouse |
| Q46870063 | CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke |
| Q38313254 | Cd14, Gbp1, and Pla2g2a: three major candidate genes for experimental IBD identified by combining QTL and microarray analyses |
| Q48701226 | Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. |
| Q38019843 | Cell type-specific gene expression and editing responses to chronic fluoxetine treatment in the in vivo mouse brain and their relevance for stress-induced anhedonia |
| Q43296887 | Chronic treatment of astrocytes with therapeutically relevant fluoxetine concentrations enhances cPLA2 expression secondary to 5-HT2B-induced, transactivation-mediated ERK1/2 phosphorylation |
| Q22003814 | Cloning and characterization of novel mouse and human secretory phospholipase A(2)s |
| Q42604316 | Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. |
| Q47438662 | Cloning of a novel phospholipase A2 from the cnidarian Adamsia carciniopados |
| Q35024444 | Creation of targeted genomic deletions using TALEN or CRISPR/Cas nuclease pairs in one-cell mouse embryos. |
| Q44391284 | Cross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for ar |
| Q37045283 | Cytokines in radiobiological responses: a review |
| Q46897544 | Cytosolic phospholipase A2 and arachidonic acid metabolites modulate ventilator-induced permeability increases in isolated mouse lungs |
| Q36331622 | Cytosolic phospholipase A2 is essential for both the immediate and the delayed phases of eicosanoid generation in mouse bone marrow-derived mast cells |
| Q44757991 | Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease |
| Q35061098 | Cytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injury |
| Q45271816 | Cytosolic phospholipase A2alpha regulates induction of brain cyclooxygenase-2 in a mouse model of inflammation |
| Q35886245 | Cytosolic phospholipase A₂: physiological function and role in disease |
| Q42492017 | Defective arachidonate release and PGE2 production in Gi alpha2-deficient intestinal and colonic subepithelial myofibroblasts |
| Q44021015 | Deficiency in sPLA(2) does not affect HDL levels or atherosclerosis in mice |
| Q36815195 | Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice |
| Q28590770 | Deletion of cytosolic phospholipase A(2) suppresses Apc(Min)-induced tumorigenesis |
| Q35542696 | Detection and quantification of microparticles from different cellular lineages using flow cytometry. Evaluation of the impact of secreted phospholipase A2 on microparticle assessment |
| Q48456623 | Detection of regulatory variation in mouse genes |
| Q73656470 | Detection of secretory phospholipase A2s related but not identical to type IIA isozyme in cultured mast cells |
| Q34951512 | Differences in mucosal gene expression in the colon of two inbred mouse strains after colonization with commensal gut bacteria |
| Q45229023 | Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages |
| Q45417670 | Differential gene expression and methylation in the retinoid/PPARA pathway and of tumor suppressors may modify intestinal tumorigenesis induced by low folate in mice |
| Q37181286 | Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. |
| Q36370888 | Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). |
| Q59050854 | Diverse Functions of Secretory Phospholipases A2 |
| Q34212477 | Diversity and regulatory functions of mammalian secretory phospholipase A2s. |
| Q53851406 | Diversity in secreted PLA2-IIA activity among inbred mouse strains that are resistant or susceptible to Apc Min/+ tumorigenesis. |
| Q40956364 | Enhancing activity and phospholipase A2 activity: two independent activities present in the enhancing factor molecule |
| Q35086017 | Estradiol-Treated Female Mice as Surrogate Hosts for Neisseria gonorrhoeae Genital Tract Infections |
| Q97644518 | Expression and Roles of Antimicrobial Peptides in Innate Defense of Airway Mucosa: Potential Implication in Cystic Fibrosis |
| Q42439190 | Expression of enhancing factor/phospholipase A2 in skin results in abnormal epidermis and increased sensitivity to chemical carcinogenesis. |
| Q37354905 | Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate |
| Q53059731 | Fetal Growth Restriction Induced by Transient Uterine Ischemia-Reperfusion: Differential Responses in Different Mouse Strains. |
| Q42497928 | Genomic characterization of the human and mouse protein tyrosine phosphatase-1B genes. |
| Q36183727 | Group IVA phospholipase A₂ optimizes ovulation and fertilization in rodents through induction of and metabolic coupling with prostaglandin endoperoxide synthase 2. |
| Q35900962 | Group V secretory PLA2 regulates TLR2-dependent eicosanoid generation in mouse mast cells through amplification of ERK and cPLA2alpha activation |
| Q35574633 | Group V secretory phospholipase A2 amplifies the induction of cyclooxygenase 2 and delayed prostaglandin D2 generation in mouse bone marrow culture-derived mast cells in a strain-dependent manner |
| Q54625811 | Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury. |
| Q35677082 | Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis |
| Q34283352 | Group X secretory phospholipase A2 regulates insulin secretion through a cyclooxygenase-2-dependent mechanism |
| Q73141391 | Group-II phospholipase A(2) enhances oxidized low density lipoprotein-induced macrophage growth through enhancement of GM-CSF release |
| Q57293438 | Harmful and protective roles of group V phospholipase A: Current perspectives and future directions |
| Q36710676 | Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse |
| Q43707867 | Helicobacter infection and phospholipase A2 enzymes: effect of Helicobacter felis-infection on the expression and activity of sPLA2 enzymes in mouse stomach |
| Q45242149 | Host-specific differences in the physiology of acid secretion related to prostaglandins may play a role in gastric inflammation and injury |
| Q34016630 | Human cancer xenografts in outbred nude mice can be confounded by polymorphisms in a modifier of tumorigenesis |
| Q33912120 | Identification of group X secretory phospholipase A(2) as a natural ligand for mouse phospholipase A(2) receptor |
| Q35003070 | Identification of the modifier of Min 2 (Mom2) locus, a new mutation that influences Apc-induced intestinal neoplasia. |
| Q34187954 | Impact of serum amyloid A on high density lipoprotein composition and levels |
| Q34349776 | Increased hepatic cholesterol accumulation in transgenic mice overexpressing human secretory phospholipase A2 group IIA. |
| Q43082422 | Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model |
| Q43204373 | Inhibition of the activity of pro-inflammatory secretory phospholipase A(2) by acute phase proteins |
| Q36992077 | Integration of cytokine biology and lipid metabolism in stroke |
| Q39320252 | Interleukin-22-Induced Antimicrobial Phospholipase A2 Group IIA Mediates Protective Innate Immunity of Nonhematopoietic Cells against Listeria monocytogenes. |
| Q37892098 | Intestinal lymphatic transport for drug delivery |
| Q33814817 | Intracellular phospholipase A(2) group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. |
| Q37401591 | Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes |
| Q43610499 | Ischemic-reperfused isolated working mouse hearts: membrane damage and type IIA phospholipase A2. |
| Q30361318 | Lack of group X secreted phospholipase A₂ increases survival following pandemic H1N1 influenza infection. |
| Q64105087 | Lipocalin 24p3 Induction in Colitis Adversely Affects Inflammation and Contributes to Mortality |
| Q46256979 | Lipopolysaccharide (LPS)-mediated priming of toll-like receptor 4 enhances oxidant-induced prostaglandin E2 biosynthesis in primary murine macrophages |
| Q47133692 | Lipoquality control by phospholipase A2 enzymes |
| Q47313532 | Localization of group IIc low molecular weight phospholipase A2 mRNA to meiotic cells in the mouse |
| Q28146023 | Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cells |
| Q73066778 | Macrophage arachidonate release via both the cytosolic Ca(2+)-dependent and -independent phospholipases is necessary for cell spreading |
| Q46493759 | Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress |
| Q45171671 | Macrophage-specific overexpression of group IIa sPLA2 increases atherosclerosis and enhances collagen deposition |
| Q34198990 | Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis |
| Q78200219 | Membrane sidedness of biosynthetic pathways involved in the production of lysophosphatidic acid |
| Q74358594 | Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection |
| Q56814708 | Model organism data evolving in support of translational medicine |
| Q40075563 | Mouse Strain Impacts Fatty Acid Uptake and Trafficking in Liver, Heart, and Brain: A Comparison of C57BL/6 and Swiss Webster Mice |
| Q34755391 | Mouse and human neutrophils induce anaphylaxis. |
| Q33557749 | Mouse strain-dependent differences in susceptibility to Neisseria gonorrhoeae infection and induction of innate immune responses |
| Q38093465 | Neutrophils in local and systemic antibody-dependent inflammatory and anaphylactic reactions. |
| Q41149645 | Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner |
| Q77317915 | On the expression of cytosolic calcium-independent phospholipase A2 (88kDa) in immature and mature myeloid cells and its role in leukotriene synthesis in human granulocytes |
| Q93019489 | PLA2G4A/cPLA2-mediated lysosomal membrane damage leads to inhibition of autophagy and neurodegeneration after brain trauma |
| Q37855523 | Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis |
| Q34219384 | Phospholipase A(2). |
| Q28609770 | Phospholipase A2 enzymes |
| Q33790580 | Phospholipase A2 enzymes in eicosanoid generation |
| Q36161810 | Phospholipase A2 in astrocytes: responses to oxidative stress, inflammation, and G protein-coupled receptor agonists |
| Q35600801 | Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases |
| Q44686150 | Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during Wallerian degeneration |
| Q34997924 | Phospholipase A2 receptor: a regulator of biological functions of secretory phospholipase A2. |
| Q35609640 | Phospholipase A2 superfamily members play divergent roles after spinal cord injury |
| Q44633175 | Phospholipase A2, Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia |
| Q34679377 | Phospholipases A2 and neural membrane dynamics: implications for Alzheimer's disease |
| Q50209896 | Phospholipid Remodeling and Cholesterol Availability Regulate Intestinal Stemness and Tumorigenesis |
| Q58086440 | Phospholipid Remodeling in Physiology and Disease |
| Q35505146 | Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA₂-IIA expression in astrocytes and microglia. |
| Q41094611 | Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2. |
| Q33823316 | Prostaglandins in bone: bad cop, good cop? |
| Q41712968 | Pseudomonas aeruginosa eradicates Staphylococcus aureus by manipulating the host immunity. |
| Q42160022 | Release of secretory phospholipase A2 from rat neuronal cells and its possible function in the regulation of catecholamine secretion |
| Q42501163 | Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2). |
| Q39513604 | Resistance of transgenic mice expressing human group II phospholipase A2 to Escherichia coli infection |
| Q43479135 | Resistance to endotoxic shock in phospholipase A2 receptor-deficient mice |
| Q33573813 | Restoration of on-time embryo implantation corrects the timing of parturition in cytosolic phospholipase A2 group IVA deficient mice |
| Q44210263 | Role of PKC and MAPK in cytosolic PLA2 phosphorylation and arachadonic acid release in primary murine astrocytes |
| Q59069879 | Role of cytosolic phospholipase A2 in allergic response and parturition |
| Q42032125 | Role of cytosolic phospholipase A2 in the production of lipid mediators and histamine release in mouse bone-marrow-derived mast cells |
| Q38009737 | Role of phospholipase A2s and lipid mediators in secondary damage after spinal cord injury. |
| Q33565825 | Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury |
| Q37167790 | Role of secretory phospholipases in atherogenesis |
| Q34997919 | Roles for cytosolic phospholipase A2alpha as revealed by gene-targeted mice |
| Q44606002 | Secreted group IIA phospholipase A2 protects humans against the group B streptococcus: experimental and clinical evidence. |
| Q40584187 | Secreted phospholipase A2 enzymes as therapeutic targets |
| Q35094556 | Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease |
| Q38701624 | Secretory phospholipase A2 group IIA modulates insulin sensitivity and metabolism. |
| Q46882730 | Secretory phospholipase A2 increases SR-BI-mediated selective uptake from HDL but not biliary cholesterol secretion |
| Q33754901 | Secretory phospholipase A2 is the principal bactericide for staphylococci and other gram-positive bacteria in human tears |
| Q33581415 | Secretory phospholipase A2, group IIA is a novel serum amyloid A target gene: activation of smooth muscle cell expression by an interleukin-1 receptor-independent mechanism |
| Q34083788 | Specific physiological roles of cytosolic phospholipase A(2) as defined by gene knockouts |
| Q22253225 | Structures, enzymatic properties, and expression of novel human and mouse secretory phospholipase A(2)s |
| Q77731446 | Suppression of murine endotoxic shock by sPLA2 inhibitor, indoxam, through group IIA sPLA2-independent mechanisms |
| Q37701322 | Targeting NADPH oxidase and phospholipases A2 in Alzheimer's disease |
| Q74083296 | The Mom1AKR intestinal tumor resistance region consists of Pla2g2a and a locus distal to D4Mit64 |
| Q38987762 | The Roles of the Secreted Phospholipase A2 Gene Family in Immunology |
| Q37077987 | The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids |
| Q28609761 | The expanding superfamily of phospholipase A(2) enzymes: classification and characterization |
| Q33657643 | The toxicology of interleukin-12: a review |
| Q36394788 | Thyroid hormone status regulates the expression of secretory phospholipases |
| Q54033886 | Toxoplasma gondii secretes a calcium-independent phospholipase A(2). |
| Q47623339 | Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse |
| Q48125289 | Up-regulation of cPLA(2) gene expression in astrocytes by all three conventional anti-bipolar drugs is drug-specific and enzyme-specific |
| Q34358492 | Using the one-lung method to link p38 to pro-inflammatory gene expression during overventilation in C57BL/6 and BALB/c mice |
| Q34135420 | Varespladib methyl in cardiovascular disease |
| Q91809321 | cPLA2 activation contributes to lysosomal defects leading to impairment of autophagy after spinal cord injury |
| Q60301744 | cPLA2α-/- sympathetic neurons exhibit increased membrane excitability and loss of N-Type Ca2+ current inhibition by M1 muscarinic receptor signaling |
| Q72991177 | mRNA differential display of acute-phase proteins in experimental Escherichia coli infection |
Search more.